Ok Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 13, 2019 at 11:02 am EDT
Share
OK Biotech Co., Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 293.280 million compared to TWD 256.233 million a year ago. Operating income was TWD 22.759 million compared to TWD 11.850 million a year ago. Net income was TWD 25.066 million compared to TWD 29.413 million a year ago. Basic earnings per share was TWD 0.34 compared to TWD 0.4 a year ago. Diluted earnings per share was TWD 0.34 compared to TWD 0.39 a year ago. For the half year, sales was TWD 575.205 million compared to TWD 551.042 million a year ago. Operating income was TWD 46.153 million compared to TWD 51.275 million a year ago. Net income was TWD 54.231 million compared to TWD 71.478 million a year ago. Basic earnings per share was TWD 0.74 compared to TWD 0.97 a year ago. Diluted earnings per share was TWD 0.73 compared to TWD 0.94 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
